Business Description
Optipharm Co Ltd
ISIN : KR7153710009
Compare
Compare
Traded in other countries / regions
153710.Korea IPO Date
2018-10-26Description
Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.38 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | -33.37 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.99 | |||||
Beneish M-Score | -3.12 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EBITDA Growth Rate | 25.7 | |||||
3-Year EPS without NRI Growth Rate | -0.2 | |||||
3-Year FCF Growth Rate | -9.8 | |||||
3-Year Book Growth Rate | -9.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.68 | |||||
9-Day RSI | 21.47 | |||||
14-Day RSI | 25.16 | |||||
6-1 Month Momentum % | -4.31 | |||||
12-1 Month Momentum % | -12.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.78 | |||||
Quick Ratio | 1.59 | |||||
Cash Ratio | 1.26 | |||||
Days Inventory | 59.76 | |||||
Days Sales Outstanding | 22.72 | |||||
Days Payable | 12.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -2.57 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.54 | |||||
Operating Margin % | -12.15 | |||||
Net Margin % | -13.24 | |||||
FCF Margin % | -16.14 | |||||
ROE % | -8.93 | |||||
ROA % | -5.69 | |||||
ROIC % | -7.28 | |||||
ROC (Joel Greenblatt) % | -8.77 | |||||
ROCE % | -6.15 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.02 | |||||
PB Ratio | 3.66 | |||||
Price-to-Tangible-Book | 3.7 | |||||
EV-to-EBIT | -45.99 | |||||
EV-to-EBITDA | -247.82 | |||||
EV-to-Revenue | 4.77 | |||||
EV-to-FCF | -30.9 | |||||
Price-to-Net-Current-Asset-Value | 16.19 | |||||
Earnings Yield (Greenblatt) % | -2.18 | |||||
FCF Yield % | -3.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Optipharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 17,775.246 | ||
EPS (TTM) (â‚©) | -161 | ||
Beta | 0.44 | ||
Volatility % | 23.21 | ||
14-Day RSI | 25.16 | ||
14-Day ATR (â‚©) | 160.132785 | ||
20-Day SMA (â‚©) | 6489.5 | ||
12-1 Month Momentum % | -12.37 | ||
52-Week Range (â‚©) | 6060 - 9300 | ||
Shares Outstanding (Mil) | 14.67 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Optipharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Optipharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Optipharm Co Ltd Frequently Asked Questions
What is Optipharm Co Ltd(XKRX:153710)'s stock price today?
The current price of XKRX:153710 is â‚©6080.00. The 52 week high of XKRX:153710 is â‚©9300.00 and 52 week low is â‚©6060.00.
When is next earnings date of Optipharm Co Ltd(XKRX:153710)?
The next earnings date of Optipharm Co Ltd(XKRX:153710) is .
Does Optipharm Co Ltd(XKRX:153710) pay dividends? If so, how much?
Optipharm Co Ltd(XKRX:153710) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |